Investing

Janux Therapeutics : JANX

JANX

Stock Data

$14.34

$0.03 (0.21%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Janux Therapeutics Inc is a trailblazer in the biopharmaceutical field, focusing on creating innovative immunotherapies for cancer treatment. Leveraging its proprietary technologies, TRACTr and TRACIr, the company is developing treatments that activate the body's own T cells to fight tumors. With a pipeline targeting various cancer markers such as PSMA, EGFR, and TROP2, Janux is dedicated to advancing cancer care. Founded in 2017 and based in San Diego, California, Janux is at the forefront of developing therapies that aim to transform cancer treatment.

All Janux Therapeutics Articles

2 Articles

Lee Jackson | Apr 15, 2026 at 7:57 AM EDT

Here Are Wednesday’s Top Wall Street Analyst Research Calls: Align Technology, American Tower, Autodesk, Autoliv, Chime Financial, Cloudflare, SolarEdge Technologies, Zoetis, and More

Pre-Market Stock Futures: The futures are trading flat after a stellar day across Wall Street, with all major indices finishing…

Trey Thoelcke | Feb 16, 2026 at 9:40 AM EST

Wall Street Thinks These 4 Biotech Stocks Will Double–At Least–This Year

Wall Street analysts are placing aggressive bets on four clinical-stage biotech companies, with consensus price targets implying gains of up…